Adenosine Triphosphate (ATP) Swab Test Market is expected to reach US$ 369.71 million in 2027

by Sameer Joshi or 25-Nov-2020
Request For Sample

Report : Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Free ATP Test and Microbial ATP Test) and Application (Pharmaceutical and Biotechnology Companies, Food and Beverage Companies, Hospitals and Diagnostics Laboratories, and Academic and Research Institutions) and Geography

Technological Advancements to be Prominent Trend in Adenosine Triphosphate (ATP) Swab Test Market

According to our new research study of “Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type and Application,” the market is expected to reach US$ 369.71 million by 2027 from US$ 198.21 million in 2019; it is estimated to grow at a CAGR of 8.2% from 2020 to 2027. The report highlights trends prevailing in the global adenosine triphosphate (ATP) swab test market and drivers and hindrances pertaining to the market growth.

ATP is major source of energy for microbes. The ATP test works on measurement of ATP molecules present on a surface. However, the ATP molecule rapidly degrades into ADP and AMP molecules. Due to this fact, ATP swab test indicates lower concentration of ATP, which can lead to miscalculations about food safety. In order to deal with this, researchers are working on the development of A3 (ATP + ADP + AMP) test to monitor cleanliness of surfaces. Some studies concluded that A3 tests have shown more precision over ATP swab test in measuring cleanliness and sanitation. In addition, A3 test is estimated to show higher sensitivity toward microbes’ differentiations as compared to conventional ATP swab tests. Products based on A3 technology are expected to offer improved accuracy in sanitation monitoring, which would eventually reshape the ATP swab test market in years to come.

In terms of geography, the global adenosine triphosphate (ATP) swab test market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. North America held the largest market share in 2019. In North America, the U.S. is the largest market for ATP swab tests. The growth of the region is attributed to presence of key market players and growing product developments. In addition, continuous product developments are further expected to stimulate the growth of Adenosine Triphosphate (ATP) swab test market in North America.

Hygiena, Llc; 3M; Charm Sciences, Inc.; Kikkoman Biochemifa; Neogen; Ecolab; Ruhof Healthcare Corporation; Luminultra Technologies Ltd.; and Merck KGaA are among the leading companies operating in the adenosine triphosphate (ATP) swab test market.

The report analyzes adenosine triphosphate (ATP) swab test market as follows:

By Type

  • Free ATP Test
  • Microbial ATP Test

By Application

  • Pharmaceutical and Biotechnology Companies
  • Food and Beverage Companies
  • Hospitals and Diagnostics Laboratories
  • Academic and Research Institutions

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South America

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com